Evidence map›Paper›PMID 17997230›Full record

ArticleNeuroscience2007

Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.

L Gendron, J E Pintar, C Chavkin

Abstract read
In one paragraph

Article in Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 64 citations in OpenAlex.

  1. The simultaneous activation of μ- and δ-opioid receptors by (-)-2Current research in pharmacology and drug discovery · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Alleviating pain with delta opioid receptor agonists: evidence from experimental models.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Review
  7. Article
  8. The Delta-Opioid Receptor; a Target for the Treatment of Pain.Frontiers in molecular neuroscience · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Molecular Pharmacology of δ-Opioid Receptors.Pharmacological reviews · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

L GendronDepartment of Pharmacology, Health Sciences Building, University of Washington, Seattle, WA 98195-7280, USA. Louis.Gendron@USherbrooke.ca
J E Pintar
C Chavkin
University of Washington · USRutgers, The State University of New Jersey · US

Funding

PILOT PROJECT 1-ROLE OF NOREPINEPHRINE IN PSYCHO BEHAVIOR TO DRUG ABUSEP01DA015916 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2002 to 2006
$5.4M
Regulation of Opioid Signaling by Tyr-PhosphorylationR37DA011672 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2004 to 2013
$2.5M
Dynorphins and Kappa Opioid Receptors in the Stress ResponseK05DA020570 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2006 to 2015
$1.2M
MODELS OF OPIOID RECEPTOR DESENSITIZATION MECHANISMSR01DA011672 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 1999 to 2003
$902k
CIHR 63497-1NIDA NIH HHS DA11672NIDA NIH HHS K05 DA020570NIDA NIH HHS P01 DA015916NIDA NIH HHS R01 DA011672NIDA NIH HHS R37 DA011672
6 · The paper itself

Abstract

Analgesic effects of delta opioid receptor (DOR) -selective agonists are enhanced during persistent inflammation and arthritis. Although the underlying mechanisms are still unknown, membrane density of DOR was shown to be increased 72 h after induction of inflammation, an effect abolished in mu opioid receptor (MOR) -knockout (KO) mice [Morinville A, Cahill CM, Kieffer B, Collier B, Beaudet A (2004b) Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain 109:266-273]. In this study, we demonstrated a crucial role of MOR in DOR-mediated antihyperalgesia. Intrathecal administration of the DOR selective agonist deltorphin II failed to induce antihyperalgesic effects in MOR-KO mice, whereas it dose-dependently reversed thermal hyperalgesia in wild-type mice. The antihyperalgesic effects of deltorphin II were blocked by naltrindole but not d-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH(2) (CTOP) suggesting that this agonist was mainly acting through DOR. SNC80-induced antihyperalgesic effects in MOR-KO mice were also attenuated as compared with littermate controls. In contrast, kappa opioid receptor knockout did not affect deltorphin II-induced antihyperalgesia. As evaluated using mice lacking endogenous opioid peptides, the regulation of DOR's effects was also independent of beta-endorphin, enkephalins, or dynorphin opioids known to be released during persistent inflammation. We therefore conclude that DOR-mediated antihyperalgesia is dependent on MOR expression but that activation of MOR by endogenous opioids is probably not required.

Indexed as

Animalsbeta-EndorphinDose-Response Relationship, DrugDynorphinsEnkephalinsFreund's AdjuvantHyperalgesiaInflammationMaleMiceMice, Inbred C57BLMice, KnockoutMotor ActivityNaltrexoneNarcotic AntagonistsOligopeptidesbeta-Endorphindeltorphin II, Ala(2)-DynorphinsEnkephalinsFreund's AdjuvantNaltrexoneNarcotic AntagonistsOligopeptidesphenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamideproenkephalinProtein PrecursorsReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, muSomatostatin

Identifiers

PMID17997230
PMCPMC2194644
OpenAlexW2095027232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.